BioCentury
ARTICLE | Company News

Eli Lilly infectious news

March 26, 2007 7:00 AM UTC

LLY will invest an additional $50 million in an initiative focused on multi-drug resistant tuberculosis (MDR-TB), bringing the pharma company’s total contribution to $120 million since 2003. The Lilly...